Zimmer Biomet Holdings, Inc.
ZBH- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001136869
In the last 90 days, Zimmer Biomet Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 913 institutions reported holding it in 13F filings for Q2 2026, worth $17.1B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $824.0K in total
- 2
- 13F holdersQ2 2026, +3 vs. previous quarter
- 913
- 13F valueReported value at the end of Q2 2026
- $17.1B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding ZBH, Q2 2026
1 superinvestor reports holding Zimmer Biomet Holdings, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Harris Associates (Oakmark)
Bill Nygren
1.5%
Zimmer Biomet Holdings, Inc.'s share of the portfolio
- Shares
- 12,738,025
- Value
- $1.10B
Latest insider trades
Open-market purchases and sales by Zimmer Biomet Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:24 PM ET | Sep 11 | 4 days | Thornal Kevin RGrp Pres-Global Business | SSale | −5.69K | $92.95 | −$529.0K | −100.0%0 after | |
| Sep 9, 2026 (view filing)4:12 PM ET | Sep 4 | 5 days | Phipps Chad FSee remarks below. | SSale | −3.00K | $98.35 | −$295.1K | −4.4%65.2K after | |
| Jun 2, 2026 (view filing) | May 29 | 4 days | Yi SangGroup President, Asia Pacific | SSale | −5.00K | $82.64 | −$413.2K | −15.5%27.3K after | 2 lots |
| Mar 16, 2026 (view filing) | Mar 12 | 4 days | Winkler LoriSVP and CHRO | SSale | −2.65K | $94.66 | −$250.8K | −20.6%10.2K after | |
| Feb 17, 2026 (view filing) | Feb 12 | 5 days | Yi SangGroup President, Asia Pacific | SSale | −1.00K | $96.49 | −$96.5K | −5.4%17.7K after | |
| Sep 15, 2025 (view filing) | Sep 11 | 4 days | Yi SangGroup President, Asia Pacific | SSale | −1.20K | $103.59 | −$124.3K | −6.1%18.6K after | |
| Sep 10, 2025 (view filing) | Sep 8 | 2 days | Winkler LoriSVP and CHRO | SSale | −1.50K | $104.15 | −$156.2K | −18.0%6.83K after | |
| Aug 20, 2025 (view filing) | Aug 18 | 2 days | Winkler LoriSVP and CHRO | SSale | −1.50K | $102.49 | −$153.7K | −15.3%8.33K after | |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Yi SangGroup President, Asia Pacific | SSale | −800 | $92.51 | −$74.0K | −3.9%19.6K after | |
| Jun 13, 2025 (view filing) | Jun 11 | 2 days | Yi SangGroup President, Asia Pacific | SSale | −1.00K | $95.00 | −$95.0K | −4.7%20.4K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Zimmer Biomet Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dodge & Cox | 24,124,735 | $2.08B | 1.09% | +582,035+2.5% | Added |
| BlackRock, Inc. | 15,614,847 | $1.34B | 0.02% | +274,041+1.8% | Added |
| Harris Associates L PSuperinvestorHarris Associates (Oakmark) | 12,738,025 | $1.10B | 1.46% | −221,914−1.7% | Reduced |
| Vanguard Capital Management LLC | 12,634,937 | $1.09B | 0.02% | −158,475−1.2% | Reduced |
| Capital International Investors | 12,183,614 | $1.05B | 0.22% | +3,064,392+33.6% | Added |
| State Street Corp | 8,877,171 | $766.3M | 0.02% | +52,044+0.6% | Added |
| Vanguard Portfolio Management LLC | 8,441,747 | $726.7M | 0.03% | −208,481−2.4% | Reduced |
| Geode Capital Management, LLC | 5,349,223 | $458.7M | 0.02% | −30,302−0.6% | Reduced |
| Price T Rowe Associates Inc | 4,797,157 | $413.0M | 0.04% | −3,202,555−40.0% | Reduced |
| Invesco Ltd. | 3,979,860 | $342.6M | 0.03% | +374,435+10.4% | Added |